ENDOLOGIX INC's ticker is and the CUSIP is 29266SAB2. A total of 12 filers reported holding ENDOLOGIX INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,489,000 | +179.0% | 2,745,000 | 0.0% | 1.44% | +165.4% |
| Q1 2019 | $892,000 | -54.6% | 2,745,000 | 0.0% | 0.54% | -50.9% |
| Q4 2018 | $1,963,000 | -31.5% | 2,745,000 | -33.9% | 1.11% | -33.5% |
| Q3 2018 | $2,866,000 | -24.9% | 4,150,000 | 0.0% | 1.67% | -49.2% |
| Q2 2018 | $3,814,000 | +7.8% | 4,150,000 | 0.0% | 3.28% | +27.7% |
| Q1 2018 | $3,537,000 | -0.2% | 4,150,000 | +6.4% | 2.57% | +21.9% |
| Q4 2017 | $3,544,000 | +20.6% | 3,900,000 | +14.7% | 2.11% | +7.1% |
| Q3 2017 | $2,939,000 | -36.9% | 3,400,000 | -39.0% | 1.97% | -40.6% |
| Q2 2017 | $4,660,000 | -15.3% | 5,575,000 | 0.0% | 3.31% | -24.7% |
| Q1 2017 | $5,504,000 | -47.9% | 5,575,000 | -54.1% | 4.40% | -62.0% |
| Q4 2016 | $10,562,000 | +31.4% | 12,150,000 | +100.0% | 11.57% | +48.2% |
| Q3 2016 | $8,035,000 | +20.1% | 6,075,000 | +18.5% | 7.81% | +0.5% |
| Q2 2016 | $6,690,000 | +55.1% | 5,125,000 | +13.9% | 7.77% | +45.0% |
| Q1 2016 | $4,312,000 | +13.7% | 4,500,000 | +28.6% | 5.36% | -9.3% |
| Q4 2015 | $3,793,000 | – | 3,500,000 | – | 5.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 3,400,000 | $2,939,000 | 1.97% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 40,500,000 | $35,030,000 | 1.58% |
| PFM Health Sciences, LP | 40,409,000 | $35,156,000 | 0.69% |
| Partner Investment Management, L.P. | 427,000 | $371,000 | 0.35% |
| LINDEN ADVISORS LP | 9,448,000 | $8,121,000 | 0.29% |
| SSI INVESTMENT MANAGEMENT LLC | 3,256,000 | $2,796,000 | 0.24% |
| AMUNDI ASSET MANAGEMENT US, INC. | 8,250,000 | $7,136,000 | 0.02% |
| Citadel Advisors | 18,560,000 | $15,866,000 | 0.01% |
| Jefferies Group LLC | 125,000 | $107,000 | 0.00% |
| Bank of New York Mellon Corp | 400,000 | $348,000 | 0.00% |